Clinical analysis of ultrasound-guided thermal ablation in initial treatment of papillary thyroid cancer: report of eleven cases of reoperation

doi:10.3877/cma.j.issn.1674-3946.2018.04.010

Abstract

Abstract:

Objective

To summarize treatment experience of patients who underwent reo-peration after thermal ablation.

Methods

From February 2014 to July 2015, clinical data of 11 patients with papillary thyroid carcinoma who underwent initial thermal ablation and reoperation were analyzed retrospectively. All patients underwent CLN, including resection of unilateral lobe with isthmus in 8 patients and total thyroidectomy in 3 patients, furthermore a patient received ipsilateral selection area lymphadenectomy.

Method

In the present retrospective study, 8 patients’ CLN were negative (72.73%). Also, residual papillary cancer tissues were found in 2 patients after ablating (18.18%). All patients were successfully followed up, with an average time of 7.8 months (3~18 months). No recurrence and metastasis.

Conclusion

Ablation therapy is not suitable for patients who meet the indications of surgery. Thermal ablation is not a radical cure for cancer. Thermal a-blation should be strictly regulated in order to guide the surgeon to determine the most appropriate surgical strategy for each patient. The present study shows reoperation may improve the prognosis.

Key words: Thyroid Neoplasms, Carcinoma, Papillary, Hyperthermia, Induced

Xinchen Liu, Shaolong Hao, Huanjie Chen, Guochang Wu, Jinyao Ning, Haitao Zheng. Clinical analysis of ultrasound-guided thermal ablation in initial treatment of papillary thyroid cancer: report of eleven cases of reoperation[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2018, 12(04): 299-301.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2018.04.010

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2018/V12/I04/299

Figures/Tables 2

References 15

[1]	李晓明．聚焦甲状腺癌外科的主要难点问题[J]．中华耳鼻咽喉头颈外科杂志.2014,49((10):793-796.
[2]	中华医学会内分泌学分会，中华医学会外科学分会内分泌外科学组，中国抗癌协会头颈肿瘤专业委员会，等．甲状腺结节和分化型甲状腺癌诊治指南[J]．中国肿瘤临床，2012,39(17):1249-1272.
[3]	Cooper DS, Doherty GM, Haugen BR，et al.Revised American Thyroid Association management guidelines for patients with thyroidnodules and differentiated thyroid cancer[J]．Thyroid，2009,19(11):1167-1214.
[4]	Dupuy DE, Monchik JM, Decrea C，et al.Radiofrequency ablation of regional recurrence from well－differentiated thyroid malignancy[J]．Surgery，2001,130(6):971-977.
[5]	Kim YS, Rhim H, Tae K，et al.Radiofrequency ablation of benign cold thyroid nodules：initial clinical experience[J]．Thyroid，2006,16(4):361-367.
[6]	章建全．经皮热消融治疗在甲状腺乳头状癌及其区域淋巴结转移中的应用前景[J/CD]．中华超声医学杂志(电子版)，2014,11(8):1-4.
[7]	Yue W, Wang S, Yu S，et al.Ultrasound－guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience[J]．Int J Hyperthermia，2014,30(2):150-157.
[8]	Na DG, Lee JH, Jung SL，et al.Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations[J]．Korean J Radiol，2012,13(2):117-125.
[9]	De Bermardi IC, Floridi C, Muollo A，et al.Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroidcancers：literature review[J]．Radiol Med，2014,119(7):512-520.
[10]	Garberoglio R, Aliberti C, Appetecchia M，et al.Radiofrequency ablation for thyroid nodules：which indication？The first Italian opinion statement[J]．J of Ultrasound，2015,18(4):423-430.
[11]	Lim HK, Baek JH, Lee JH，et al.Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer[J]．Eur Radiol，2015,25(1):163-170.
[12]	Kim JH, Yoo WS, Park YJ，et al.Efficacy and Safety of Radiofrequency Ablation for Treatment of Locally Recurrent Thyroid Cancers Smaller than 2cm[J]．Radiology，2015,276(3):909-918.
[13]	董文武，张浩，张平，等．甲状腺乳头状癌射频消融治疗后在手术5例临床分析[J]．中国实用外科杂志，2015,35(6):653-655.
[14]	Ma B, Wang Y, Yang S，et al.Predictive factors for centrallymph node metastasis in patients with cN0 papillary thyroid carcinoma：A systematic review and meta－analysis[J]．Int J Surg，2016,28:153-161.
[15]	Jovanovic L, Delahunt B, McIver B，et al. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonalevolution following the intra－glandular spread of the initial neoplastic clone[J]．J Pathol，2008,215(2):145-154.

Please choose a citation manager

Content to export